Best treatments for ovarian neoplasms

Understanding ovarian neoplasms

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones. The most common type is ovarian epithelial cancer, which begins in the cells that cover the ovary. Fallopian tube cancer and primary peritoneal cancer form in the same type of tissue and are generally treated the same way (NCI, MedlinePlus). Early-stage disease often causes no clear signs. When symptoms do appear, they may include bloating; pain or a feeling of pressure in the abdomen or pelvis; trouble eating or feeling full quickly; and urinary urgency or frequency. The American Cancer Society notes that when these are caused by ovarian cancer they tend to be persistent and a change from what is normal. To evaluate symptoms, a clinician may perform a pelvic exam, order imaging such as ultrasound or CT, and use a CA-125 blood test; often the only way to confirm the diagnosis is a biopsy of tissue, usually done during surgery (MedlinePlus, NCI). This is general information, not medical advice.

Frequently asked

What treats ovarian neoplasms?

Our catalog lists 24 products that may treat ovarian neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is mvasi.

What is the best-rated treatment for ovarian neoplasms?

By our independent recall-safety rating — not an efficacy measure — mvasi ranks highest among the products we list for ovarian neoplasms. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat ovarian neoplasms?

Treatments for ovarian neoplasms span FDA drug classes including vascular endothelial growth factor inhibitor, microtubule inhibitor, alkylating drug, gonadotropin releasing hormone receptor agonist, nucleoside metabolic inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.